Tonghua Dongbao Pharmaceutical Co., Ltd.

Symbol: 600867.SS

SHH

10.3

CNY

Market price today

  • 18.2244

    P/E Ratio

  • 0.0089

    PEG Ratio

  • 20.25B

    MRK Cap

  • 0.02%

    DIV Yield

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.80%

Operating Profit Margin

0.42%

Net Profit Margin

0.38%

Return on Assets

0.14%

Return on Equity

0.16%

Return on Capital Employed

0.17%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO:Mr. Sheng Leng Chun
Full-time employees:3196
City:Tonghua
Address:Dongbao New Village
IPO:1994-08-24
CIK:

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.796% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.420%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.378%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.143% return, is a testament to Tonghua Dongbao Pharmaceutical Co., Ltd.'s adeptness in optimizing resource deployment. Tonghua Dongbao Pharmaceutical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.162%. Furthermore, the proficiency of Tonghua Dongbao Pharmaceutical Co., Ltd. in capital utilization is underscored by a remarkable 0.168% return on capital employed.

Stock Prices

Tonghua Dongbao Pharmaceutical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $10.93, while its low point bottomed out at $10.29. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Tonghua Dongbao Pharmaceutical Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 600867.SS liquidity ratios reveals its financial health of the firm. The current ratio of 665.72% gauges short-term asset coverage for liabilities. The quick ratio (484.95%) assesses immediate liquidity, while the cash ratio (248.15%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio665.72%
Quick Ratio484.95%
Cash Ratio248.15%

Profitability Ratios

600867.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 42.20% underscores its earnings before tax deductions. The effective tax rate stands at 14.36%, revealing its tax efficiency. The net income per EBT, 89.60%, and the EBT per EBIT, 100.46%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 42.01%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin42.20%
Effective Tax Rate14.36%
Net Income per EBT89.60%
EBT per EBIT100.46%
EBIT per Revenue42.01%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 6.66, it details the span from stock purchase to revenue. The 5 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 323.99% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding485
Days of Inventory Outstanding419
Operating Cycle532.13
Days of Payables Outstanding72
Cash Conversion Cycle460
Receivables Turnover3.24
Payables Turnover5.09
Inventory Turnover0.87
Fixed Asset Turnover1.13
Asset Turnover0.38

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.44, and free cash flow per share, 0.27, depict cash generation on a per-share basis. The cash per share value, 0.59, showcases liquidity position. A payout ratio of 0.44 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.29, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.44
Free Cash Flow per Share0.27
Cash per Share0.59
Payout Ratio0.44
Operating Cash Flow Sales Ratio0.29
Free Cash Flow to Operating Cash Flow Ratio0.61
Cash Flow Coverage Ratio3.74
Short Term Coverage Ratio3.74
Capital Expenditure Coverage Ratio2.58
Dividend Paid and Capex Coverage Ratio1.03
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.91%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.03, we discern the balance between debt and equity financing. An interest coverage of 177.64 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio2.91%
Debt Equity Ratio0.03
Total Debt to Capitalization3.00%
Interest Coverage177.64
Cash Flow to Debt Ratio3.74
Company Equity Multiplier1.06

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.55, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.59, reflects the portion of profit attributed to each share. The book value per share, 3.65, represents the net asset value distributed per share, while the tangible book value per share, 2.99, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.55
Net Income Per Share0.59
Book Value Per Share3.65
Tangible Book Value Per Share2.99
Shareholders Equity Per Share3.65
Interest Debt Per Share0.08
Capex Per Share-0.18

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 10.18%, indicates top-line expansion, while the gross profit growth, 9.75%, reveals profitability trends. EBIT growth, -30.53%, and operating income growth, -30.53%, offer insights into operational profitability progression. The net income growth, -26.17%, showcases bottom-line expansion, and the EPS growth, -26.25%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth10.18%
Gross Profit Growth9.75%
EBIT Growth-30.53%
Operating Income Growth-30.53%
Net Income Growth-26.17%
EPS Growth-26.25%
EPS Diluted Growth-26.25%
Weighted Average Shares Growth0.37%
Weighted Average Shares Diluted Growth0.37%
Dividends per Share Growth-54.73%
Operating Cash Flow Growth2.51%
Free Cash Flow Growth44.46%
10-Year Revenue Growth per Share124.64%
5-Year Revenue Growth per Share17.55%
3-Year Revenue Growth per Share8.18%
10-Year Operating CF Growth per Share253.66%
5-Year Operating CF Growth per Share4.32%
3-Year Operating CF Growth per Share-24.16%
10-Year Net Income Growth per Share461.10%
5-Year Net Income Growth per Share44.00%
3-Year Net Income Growth per Share28.35%
10-Year Shareholders Equity Growth per Share220.02%
5-Year Shareholders Equity Growth per Share57.83%
3-Year Shareholders Equity Growth per Share32.69%
10-Year Dividend per Share Growth per Share142.75%
5-Year Dividend per Share Growth per Share44.74%
3-Year Dividend per Share Growth per Share22.99%
Receivables Growth77.87%
Inventory Growth7.87%
Asset Growth15.13%
Book Value per Share Growth9.78%
Debt Growth5560.38%
R&D Expense Growth-52.86%
SGA Expenses Growth4.90%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 20,448,638,439.18, captures the company's total value, considering both debt and equity. Income quality, 0.76, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 2.26%, highlights investment in innovation. The ratio of intangibles to total assets, 17.22%, indicates the value of non-physical assets, and capex to operating cash flow, -39.35%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value20,448,638,439.18
Income Quality0.76
Sales General and Administrative to Revenue0.01
Research and Development to Revenue2.26%
Intangibles to Total Assets17.22%
Capex to Operating Cash Flow-39.35%
Capex to Revenue-11.37%
Capex to Depreciation-168.10%
Graham Number6.96
Return on Tangible Assets18.15%
Graham Net Net0.85
Working Capital2,296,193,953
Tangible Asset Value5,905,537,449
Net Current Asset Value2,288,781,228
Average Receivables716,138,493.5
Average Payables98,380,453.5
Average Inventory679,620,525
Days Sales Outstanding109
Days Payables Outstanding61
Days of Inventory On Hand373
ROIC14.58%
ROE0.16%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.78, and the price to book ratio, 2.78, reflect the market's valuation relative to the company's book value. The price to sales ratio, 6.85, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 38.89, and price to operating cash flows, 23.95, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.78
Price to Book Ratio2.78
Price to Sales Ratio6.85
Price Cash Flow Ratio23.95
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple15.78
Price Fair Value2.78
Price to Operating Cash Flow Ratio23.95
Price to Free Cash Flows Ratio38.89
Price to Tangible Book Ratio2.97
Enterprise Value to Sales6.68
Enterprise Value Over EBITDA13.84
EV to Operating Cash Flow23.11
Earnings Yield5.46%
Free Cash Flow Yield2.51%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 18.224 in 2024.

What is the ticker symbol of Tonghua Dongbao Pharmaceutical Co., Ltd. stock?

The ticker symbol of Tonghua Dongbao Pharmaceutical Co., Ltd. stock is 600867.SS.

What is company IPO date?

IPO date of Tonghua Dongbao Pharmaceutical Co., Ltd. is 1994-08-24.

What is company current share price?

Current share price is 10.300 CNY.

What is stock market cap today?

The market cap of stock today is 20251799704.000.

What is PEG ratio in 2024?

The current 0.009 is 0.009 in 2024.

What is the number of employees in 2024?

In 2024 the company has 3196.